Another view on medical trends for 2020, this time around the world, is provided by large benefit consultant and broker WillisTowersWatson. (WTW Report) The report is based on responses from 296 insurers in 79 countries. The global medical trend is expected to be 6.8% in 2020, similar to the 6.7% trend projected for this year. South and Latin America have the highest rate of growth at 12.2% and the MidEast and Africa are also up there with a 9.3% increase, while Europe is more sedate at 4.3%. In the United States it was 7.2%, down modestly from the past two years. China, with largest population, is experiencing quite high trend of 9.8%. Of course, some of those South American countries, i.e., Venezuela, have substantial inflation issues and drive up overall regional trend. No region is expecting lower trends over the next three years and over 40% of respondents said they expect higher trends in that period. In no region is medical trend below general inflation and in most it is several percentage points above. The most significant conditions driving spending around the world are cited as being cancer, cardiovascular conditions and musculoskeletal conditions, but respondents expect mental health and substance abuse to become a dominant factor over the next few years. In all seriousness, with the level of geopolitical and personal stress around the world, I am sure there will be more mental health and substance abuse issues. Insurers blame overuse of treatment by providers, cited by 73% of payers, and by patients, cited by 66%, for the increase in medical spending, along with new technology costs. Another 41% point the finger at poor patient health habits and 28% say underuse of preventive care contributes. The primary method they expect to use for cost control is coinsurance, which is a very blunt instrument for accomplishing that objective. Dumping costs on patients or limiting benefit access for some services is far and away the most common spending management approach. Apparently actually managing care and health is too much work. Don’t expect any sympathy from me if you really don’t care about the health of the patients you are insuring.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Two health care firms owned by private equity firms are merging in a transaction supposedly valued at $3 billion. HealthComp administers self-funded plans for employers and other groups and Virgin...
September 27, 2023
NextGen, an electronic medical records firm, is being put out of its public company misery, as a PE firm will pay $1.6 billion for the one-time high-flier.
September 7, 2023
A number of companies which attracted large financing rounds during the epidemic have imploded when reality set in. The latest is Cano Health, which is a little surprising since it...
August 15, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace